GGrantIndex
Sort

78,016 grants matching breast cancer

Columbus NCORP RFA-CA-18-016

$825,770
Timothy David Moore · Columbus Community Clinical Oncology Prg · UG1 · FY2020 · CA

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial

$825,573
Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2022 · CA

Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers

$825,543
Steven A. Carr · Broad Institute, Inc. · U24 · FY2016 · CA

Research Project 1: Identification and validation of efficacious therapies for breast cancer using patient-derived specimens

$825,486
Alana L Welm · University Of Utah · U54 · FY2017 · CA

Environmental chemicals and postpubertal breast composition in a Latino cohort

$825,456
Karin B Michels · University Of California Los Angeles · U01 · FY2017 · ES

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer

$825,302
Carol J Fabian · University Of Kansas Medical Center · R01 · FY2025 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$825,166
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Duluth Community Clinical Oncology Program

$825,164
Daniel A Nikcevich · Duluth Clinic, Ltd. · U10 · FY2006 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$825,123
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance

$825,000
Robert David Schreiber · Washington University · U01 · FY2009 · CA

Statistical Coordinating Center for the Breast Cancer Surveillance Consortium

$824,946
Diana L Miglioretti · Kaiser Foundation Health Plan Of Washington · U01 · FY2009 · CA

Tumor subtypes and therapy response in pancreatic cancer

$824,656
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA

New Technology for Functional Studies of the Kinome

$824,491
Igor A. Kozlov · Prognosys Biosciences, Inc. · R44 · FY2012 · GM

Systemic Racism and Biological Embodiment of Risk in Breast Cancer Mortality

$824,471
Tomi F Akinyemiju · Duke University · R01 · FY2022 · CA

FOOD (Food to Overcome Outcomes Disparities)

$824,082
Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Missouri Valley Cancer Consortium CCOP

$823,998
Missouri Valley Cancer Consortium, Inc. · U10 · FY2004 · CA

Stroger Hospital of Cook County, MBCCOP

$823,820
Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2011 · CA

Columbus NCORP RFA-CA-18-016

$823,797
Timothy David Moore · Columbus Community Clinical Oncology Prg · UG1 · FY2021 · CA

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Clinical Trials Development & Member Site Core

$823,778
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2022 · CA

A PROSPECTIVE STUDY OF DIET AND CANCER IN WOMEN

$823,745
Brigham And Women'S Hospital · R01 · FY2000 · CA

Clinical production of viral vectors for cancer gene therapy

$823,336
Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis

$823,071
Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2011 · CA

Development of TGF-beta antagonists for cancer therapy

$823,023
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Targeting Neuroblastoma with armed T cells

$822,924
Lawrence G Lum · University Of Virginia · R01 · FY2016 · CA

Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance

$822,738
Bryan E. Welm · University Of Utah · U01 · FY2018 · CA